Stem Cell Contract Research & Services, Stem Cell Therapy

StemCellerant is at the forefront of advancing stem cell therapeutics through its innovative Accelerated Differentiation technology. This proprietary method allows for the direct differentiation of stem cells into functional, terminally-differentiated cell types, significantly reducing the time required for this process from weeks to just a few days. By bypassing many of the traditional intermediate stages of differentiation, StemCellerant enhances the safety and efficacy of stem cell therapies, making them more accessible for applications in drug discovery, disease modeling, and basic research. The technology is designed to produce high-quality cells that are physiologically and morphologically similar to primary cells, achieving a purity level of up to 95%.

In addition to its rapid differentiation capabilities, StemCellerant's technology is robust and reproducible across various users and cell lines, allowing for scalability in applications such as proteomics. The company offers a customizable service that provides a range of differentiated cell types, including skeletal muscle cells, neurons, endothelial cells, and more. This versatility positions StemCellerant as a key player in the field of personalized regenerative medicine, with the potential to revolutionize treatment options for a variety of diseases.

United States

StemCellerant designs and manufactures stem cell based research tools and therapeutics with a mission to accelerate personalized regenerative medicine.

StemCellerant

Company Details